{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T10:47:55Z","timestamp":1773053275674,"version":"3.50.1"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T00:00:00Z","timestamp":1576454400000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"JSPS Kakenhi","award":["17K13037"],"award-info":[{"award-number":["17K13037"]}]},{"name":"JSPS Kakenhi","award":["15K19381"],"award-info":[{"award-number":["15K19381"]}]},{"name":"JSPS Kakenhi","award":["17K09506"],"award-info":[{"award-number":["17K09506"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Cardiac amyloidosis (CA) is a secondary form of cardiomyopathy where abnormal accumulation of amyloid protein in the myocardial interstitium causes cardiac hypertrophy and myocardial fibrosis. If primary CA advances to heart failure, most patients do not survive for very long after the diagnosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case summary<\/jats:title>\n                  <jats:p>A 40-year-old man was admitted to our hospital for dyspnoea, progressive anaemia, and decreased appetite. He has diagnosed with amyloid light-chain (AL) amyloidosis. Although BD treatment (bortezomib + dexamethasone) and medical treatment were started, there was no sign of improvement. Then, high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation (auto-PBSCT) was initiated. Pretreatment echocardiography revealed typical findings of CA, such as ventricular wall thickening, valvular thickening, diastolic dysfunction, and pericardial effusion. Global longitudinal strain (GLS) was significantly reduced, and bull's-eye mapping showed typical apical sparing. After auto-PBSCT, GLS gradually improved and was almost normal after 2\u2009years. Other echocardiographic parameters, functional status, and laboratory data also showed that there was significant regression of CA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Although the prognosis in primary CA is extremely poor, we achieved long-term survival in a patient with effective high-dose chemotherapy and auto-PBSCT. Global longitudinal strain may be a useful marker of prognosis, regression, and recovery.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytz225","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T06:57:25Z","timestamp":1576479445000},"page":"1-6","source":"Crossref","is-referenced-by-count":9,"title":["Improvement of global longitudinal strain following high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with amyloid light-chain cardiac amyloidosis: a case report"],"prefix":"10.1093","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3379-9387","authenticated-orcid":false,"given":"Yukina","family":"Hirata","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Ultrasound Examination Center, Tokushima University Hospital, 2-50-1 Kuramoto, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4909-754X","authenticated-orcid":false,"given":"Kenya","family":"Kusunose","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Ultrasound Examination Center, Tokushima University Hospital, 2-50-1 Kuramoto, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Miki","sequence":"first","affiliation":[{"name":"Division of Transfusion Medicine and Cell Therapy, Tokushima University Hospital, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3741-5560","authenticated-orcid":false,"given":"Hirotsugu","family":"Yamada","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Ultrasound Examination Center, Tokushima University Hospital, 2-50-1 Kuramoto, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,12,16]]},"reference":[{"key":"2020021802000320500_ytz225-B1","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM199709253371306","article-title":"The systemic amyloidosis","volume":"337","author":"Falk","year":"1997","journal-title":"N Engl J Med"},{"key":"2020021802000320500_ytz225-B2","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"Phelan","year":"2012","journal-title":"Heart"},{"key":"2020021802000320500_ytz225-B3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/qjmed\/91.2.141","article-title":"The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement","volume":"91","author":"Dubrey","year":"1998","journal-title":"QJM"},{"key":"2020021802000320500_ytz225-B4","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.hlc.2013.01.013","article-title":"The return of the normal heart: resolution of cardiac amyloidosis after chemotherapy and bone marrow transplantation","volume":"22","author":"Fitzgerald","year":"2013","journal-title":"Heart Lung Circ"},{"key":"2020021802000320500_ytz225-B5","first-page":"46","article-title":"Regression of the anatomic cardiac features of amyloid light chain cardiac amyloidosis accompanied by normalization of global longitudinal strain","volume":"1","author":"Fitzgerald","year":"2017","journal-title":"CASE (Phila)"},{"key":"2020021802000320500_ytz225-B6","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1161\/CIRCULATIONAHA.110.010447","article-title":"Cardiac amyloidosis: a treatable disease, often overlooked","volume":"124","author":"Falk","year":"2011","journal-title":"Circulation"},{"key":"2020021802000320500_ytz225-B7","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1038\/leu.2016.191","article-title":"Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with al amyloidosis","volume":"30","author":"Merlini","year":"2016","journal-title":"Leukemia"},{"key":"2020021802000320500_ytz225-B8","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/ehjci\/jew298","article-title":"Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis","volume":"18","author":"Salinaro","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2020021802000320500_ytz225-B9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/13506129.2011.574354048","article-title":"Regression of cardiac wall thickness following chemotherapy and stem cell transplantation for light chain (AL) amyloidosis","volume":"18","author":"Meier-Ewert","year":"2011","journal-title":"Amyloid"},{"key":"2020021802000320500_ytz225-B10","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jacc.2012.04.043","article-title":"Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers","volume":"60","author":"Buss","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2020021802000320500_ytz225-B11","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1161\/CIRCIMAGING.113.000683","article-title":"Effect of combined systolic and diastolic functional parameter assessment for differentiation of cardiac amyloidosis from other causes of concentric left ventricular hypertrophy","volume":"6","author":"Liu","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2020021802000320500_ytz225-B12","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.amjcard.2017.07.025","article-title":"Functional cardiac recovery and hematologic response to chemotherapy in patients with light-chain amyloidosis (from the Stanford University Amyloidosis Registry)","volume":"120","author":"Tuzovic","year":"2017","journal-title":"Am J Cardiol"},{"key":"2020021802000320500_ytz225-B13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jcmg.2015.05.014","article-title":"Causes and consequences of longitudinal LV dysfunction assessed by 2D strain echocardiography in cardiac amyloidosis","volume":"9","author":"Ternacle","year":"2016","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ehjcr\/article-pdf\/3\/4\/1\/32501499\/ytz225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ehjcr\/article-pdf\/3\/4\/1\/32501499\/ytz225.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T02:00:15Z","timestamp":1581991215000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/3\/4\/1\/5678686"}},"subtitle":[],"editor":[{"given":"Matteo","family":"Cameli","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Liga","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Savvas","family":"Loizos","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Mark Philip","family":"Cassar","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Ross","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,12,1]]},"references-count":13,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,12,16]]},"published-print":{"date-parts":[[2019,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytz225","relation":{},"ISSN":["2514-2119"],"issn-type":[{"value":"2514-2119","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12]]},"published":{"date-parts":[[2019,12,1]]}}}